LEXICON PHARMACEUTICALS, INC. (LXRX) Net income 2016–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$50.3MFY2025 · since FY2016: -$131.4M → -$50.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.3M | +74.9% |
| FY2024 | -$200.4M | -13.1% |
| FY2023 | -$177.1M | -73.7% |
| FY2022 | -$101.9M | -16.2% |
| FY2021 | -$87.8M | -49.8% |
| FY2020 | -$58.6M | -145.0% |
| FY2019 | $130.1M | +208.0% |
| FY2018 | -$120.5M | +2.0% |
| FY2017 | -$123.0M | +6.4% |
| FY2016 | -$131.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LXRX financial trends
LXRX RevenueLXRX Net marginLXRX Gross profitLXRX Gross marginLXRX Operating incomeLXRX Operating marginLXRX Operating cash flowLXRX Free cash flowLXRX Capital expendituresLXRX Return on equityLXRX Stock buybacksLXRX Dividends paidLXRX Total assetsLXRX Total liabilitiesLXRX Shareholders’ equityLXRX overview →